Uterine fibroids are benign tumors that occur in the smooth muscle of the uterus and are the most common tumor of the female reproductive system. 20-25% of women have fibroids, and the incidence is higher in women over 50 years of age who are still menstruating (40%). Fibroids can occur at any time between the onset of menstruation and menopause, but the most common age of onset is 35-49 years, with a gradual improvement after menopause. Depending on the location, fibroids can be classified as subplasmic fibroids, interstitial fibroids, and subendometrial fibroids, and are usually treated by surgical excision for symptomatic fibroids, often requiring removal of the uterus for larger fibroids. Because of the trauma and complications associated with surgery, as well as the slow growth of fibroids and the low incidence of malignancy, non-surgical treatment is gaining more and more attention as people’s quality of life improves, and the preservation of the uterus is more urgent for young women with fertility requirements. Interventional therapy is playing an increasingly important role in the treatment of gynecologic tumors. Interventional therapy is suitable for all age groups and all kinds of severe symptomatic fibroids, with no significant impact on the normal physiological functions of the uterus and ovaries, and with significantly fewer recent and long-term complications than surgery.